Company / Gross Profit
CANNAPHARMARX, INC. Gross Profit History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
-$2.1M
FY2025
5-year range
-$2.9M / -$2.1M
FY2024-FY2025
Trend
+29.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$2M in FY2025.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit increased 29.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.1M | +29.0% |
| FY2024 | -$2.9M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026